T815-0937 Screening compound: 2-(4-CHLOROPHENOXY)-1-[3-(PROPAN-2-YL)-5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7-YL]PROPAN-1-ONE

T815-0937 Screening compound: 2-(4-CHLOROPHENOXY)-1-[3-(PROPAN-2-YL)-5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7-YL]PROPAN-1-ONE
T815-0937 Screening compound: 2-(4-CHLOROPHENOXY)-1-[3-(PROPAN-2-YL)-5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7-YL]PROPAN-1-ONE alternative view

Chemical Structure Depiction of ChemDiv screening compound T815-0937
2-(4-CHLOROPHENOXY)-1-[3-(PROPAN-2-YL)-5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7-YL]PROPAN-1-ONE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T815-0937

Molecular Formula

C17H21ClN4O2 (C17 H21 ClN4 O2)

Compound Name

2-(4-CHLOROPHENOXY)-1-[3-(PROPAN-2-YL)-5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7-YL]PROPAN-1-ONE

IUPAC name

2-(4-chlorophenoxy)-1-[3-(propan-2-yl)-5H6H7H8H-[124]triazolo[43-a]pyrazin-7-yl]propan-1-one

SMILES

CC(C)c1nnc(C2)n1CCN2C(C(C)Oc(cc1)ccc1Cl)=O

InChI

InChI=1S/C17H21ClN4O2/c1-11(2)16-20-19-15-10-21(8-9-22(15)16)17(23)12(3)24-14-6-4-13(18)5-7-14/h4-7,11-12H,8-10H2,1-3H3/t12-/m0/s1

InChI Key

VXRALORSZOWKIU-LBPRGKRZSA-N

MDL Number (MFCD)

MFCD29027673

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

348.83

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.388

Distribution Coefficient, logD

2.387

Water Solubility, LogSw

-2.89

Polar Surface Area

48.382

Acid Dissociation Constant (pKa)

21.33

Base Dissociation Constant (pKb)

4.49

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

47.10

T815-0937 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anti-infective Library (19449 compounds)

Anti-Inflammatory Library (24602 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

SmartTM Library (51161 compounds)

TLR-8 ligands Library (674 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Female
  • Skin
  • Immune system
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • Epigenetic
Targets:
  • Others
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T815-0937 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T815-0937?
Check Price and Availability of T815-0937, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T815-0937 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T815-0937
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T815-0937
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T815-0937 available by request